Faculty profile

Patrick Veit-Haibach

Back to faculty

ProfessorDepartment of Medical ImagingUniversity of Toronto

Patrick Veit-Haibach

Professor

Department of Medical Imaging

Temerty Faculty of Medicine

University of Toronto

Toronto, Ontario, Canada

Supervision signals

Professors usually supervise graduate students in their department's programs.
79 publications in the last five years, latest in 2026.
Senior (last) author on 39 recent papers, a sign of leading a research group.

These signals come from public records, including CIHR, NSERC and SSHRC funding decisions. Ask the professor or the graduate program whether they are taking new students.

Academic metrics

113

Publications

110

Citations

Collaborators

Grants

Publications by year

Counts cover the publications linked to this profile. Citations and the h-index appear when the source records them.

Profiles and links

University Profile Search on Google Scholar

Find them onX · LinkedIn · Bluesky · YouTube

Signals and details

Research

Read how they describe their research on their University of Toronto profile.

Latest papers

Non-invasive screening in hereditary cancer: a randomized controlled trial to test cell-free DNA-based early detection in the CHARM consortium
European Journal of Human Genetics · 2026
Diagnostic and Prognostic Value of Hypoxia PET in Glioma: A Systematic Review and Meta-Analysis.
Cancers · 2026 · senior author
The PRIMARY Scoring System on PSMA PET for Clinically Significant Prostate Cancer Detection: A Systematic Review and Meta-Analysis.
Clinical nuclear medicine · 2026

All 113 publications

Latest funding

Evaluating the additional efficacy of metabolic surgery vs optimal medical therapy in type 2 diabetes and cardiovascular disease
CIHR · 2020 · Co-investigator
Auger Electron Radioimmunotherapy for Treatment and Prevention of Metastases from Triple-Negative Breast Cancer
CIHR · 2017 · Co-investigator
$684,675

All 2 grants and awards

113 publications.

Non-invasive screening in hereditary cancer: a randomized controlled trial to test cell-free DNA-based early detection in the CHARM consortium

Farncombe KM, Sobotka JA, Aronson M, Basik M, Bombard Y, Born L, Cheifetz R, Clausen M, Coburn N, Dawson L

European Journal of Human Genetics20263 citations

DOI: 10.1038/s41431-026-02014-z

Diagnostic and Prognostic Value of Hypoxia PET in Glioma: A Systematic Review and Meta-Analysis.

Ladak AM, Mirshahvalad SA, Farag A, Metser U, Ortega C, Murad V, Veit-Haibach P

Cancers2026Senior author

DOI: 10.3390/cancers18121898 PMID: 42352433

The PRIMARY Scoring System on PSMA PET for Clinically Significant Prostate Cancer Detection: A Systematic Review and Meta-Analysis.

Mourato FA, Schmitt LG, Mariussi M, Torri G, Altmayer S, Metser U, Veit-Haibach P, Brandão S, Purysko AS, Woo S, Dias AB

Clinical nuclear medicine2026

DOI: 10.1097/rlu.0000000000006309 PMID: 41631935

Prognostic Value of Interim [18F]FDG PET in Large B-Cell Lymphoma: A Systematic Review and Meta-analysis with a Particular Focus on Interim Deauville Score 5 Disease.

Mirshahvalad SA, Hodgson D, Kuruvilla J, Veit-Haibach P, Ortega C, Metser U

Journal of nuclear medicine : official publication, Society of Nuclear Medicine2026

DOI: 10.2967/jnumed.125.271089 PMID: 41545069

Prognostic Value of [ 18 F]FDG PET/CT in Multiple Myeloma Patients at the Time of Initial Diagnosis.

Mirshahvalad SA, Alghamdi A, Chavoshi M, Felder C, Metser U, Kukreti V, Lancman G, Stewart AK, Veit-Haibach P

Clinical nuclear medicine2026Senior author

DOI: 10.1097/rlu.0000000000006270 PMID: 41428382

Theranostic: A Primer for Radiologists.

Mirshahvalad SA, Beheshti M, Metser U, Jiang DM, Wong R, Alrekhais I, Veit-Haibach P

Canadian Association of Radiologists journal = Journal l'Association canadienne des radiologistes2026Senior author

DOI: 10.1177/08465371251338032 PMID: 40405808

Correction: Added prognostic value of baseline pre-infusion 18F-FDG PET/CT in diffuse large B-cell lymphoma patients receiving chimeric antigen receptor T-cell therapy.

Mirshahvalad SA, Kohan A, Kulanthaivelu R, Ortega C, Metser U, Hodgson D, Kridel R, Chen C, Bhella S, Veit-Haibach P

Scientific reports2026Senior author

DOI: 10.1038/s41598-026-36849-9 PMID: 41606040

Prognostic value of [18F]FAZA PET/MR imaging pre and post revascularization in chronic limb-threatening ischemia: a prospective pilot study on tissue microcirculation.

Mirshahvalad SA, Farag A, Sekine T, Kohan A, Mafeld S, Roche-Nagle G, Byrne J, Metser U, Tan K, Veit-Haibach P

European journal of nuclear medicine and molecular imaging2026Senior author

DOI: 10.1007/s00259-025-07514-6 PMID: 40815391

Quantification of global gray matter amyloid-β plaque from 18F-Florbetaben PET/MRI and correlation to BAPL score in patients with cognitive impairment.

Farag A, Mirshahvalad SA, Ortega C, Tartaglia C, Veit-Haibach P, Metser U

Alzheimer's & dementia (Amsterdam, Netherlands)2026

DOI: 10.1002/dad2.70449 PMID: 42591921

Predictors and prevalence of lateral supraclavicular lymph node metastases on [18F]FDG PET/CT in patients with locally advanced, or multifocal invasive ductal carcinoma of breast: potential impact on adjuvant radiotherapy targets.

Metser U, Mirshahvalad SA, Murad V, Veit-Haibach P, Han E

Frontiers in oncology2026

DOI: 10.3389/fonc.2026.1916551 PMID: 42614260

Profile data last refreshed on September 25, 2026 from the university directory, publication records and CIHR, NSERC and SSHRC funding.

Something wrong or missing on this profile? Suggest a correction

Patrick Veit-Haibach

Research

Latest papers

Latest funding

Non-invasive screening in hereditary cancer: a randomized controlled trial to test cell-free DNA-based early detection in the CHARM consortium

Diagnostic and Prognostic Value of Hypoxia PET in Glioma: A Systematic Review and Meta-Analysis.

The PRIMARY Scoring System on PSMA PET for Clinically Significant Prostate Cancer Detection: A Systematic Review and Meta-Analysis.

Prognostic Value of Interim [18F]FDG PET in Large B-Cell Lymphoma: A Systematic Review and Meta-analysis with a Particular Focus on Interim Deauville Score 5 Disease.

Prognostic Value of [ 18 F]FDG PET/CT in Multiple Myeloma Patients at the Time of Initial Diagnosis.

Theranostic: A Primer for Radiologists.

Correction: Added prognostic value of baseline pre-infusion 18F-FDG PET/CT in diffuse large B-cell lymphoma patients receiving chimeric antigen receptor T-cell therapy.

Prognostic value of [18F]FAZA PET/MR imaging pre and post revascularization in chronic limb-threatening ischemia: a prospective pilot study on tissue microcirculation.

Quantification of global gray matter amyloid-&#x3b2; plaque from 18F-Florbetaben PET/MRI and correlation to BAPL score in patients with cognitive impairment.

Predictors and prevalence of lateral supraclavicular lymph node metastases on [18F]FDG PET/CT in patients with locally advanced, or multifocal invasive ductal carcinoma of breast: potential impact on adjuvant radiotherapy targets.

Evaluating the additional efficacy of metabolic surgery vs optimal medical therapy in type 2 diabetes and cardiovascular disease

Auger Electron Radioimmunotherapy for Treatment and Prevention of Metastases from Triple-Negative Breast Cancer

Frequent collaborators

Elena Elimova

Jonathan Yeung

Alejandro Berlin

Lisa Avery

Nathan Perlis

David Hodgson

Kate Hanneman

Robert Kridel

Andrew Hope

Amy Liu

Glenn Bauman

Wei Xu

Osvaldo Espin Garcia

Xuan Li

Sareh Keshavarzi

John Kim

David Malkin

Yasbanoo Moayedi

Natalie Coburn

Antonio Finelli

John Kuruvilla

Ivan Yeung

Gonzalo Sapisochin

Osvaldo Espin Garcia

Jonathan Thiessen

Daryl Gray

Holly Etchegary

Quantification of global gray matter amyloid-β plaque from 18F-Florbetaben PET/MRI and correlation to BAPL score in patients with cognitive impairment.